A Safe and Novel Desensitization Protocol with Ferric Carboxymaltose to Treat Iron Deficiency Anemia

E-ISSN： 2212-3911|11|2|145-148

ISSN： 1574-8863

Source： Current Drug Safety, Vol.11, Iss.2, 2016-04, pp. : 145-148

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravenous ferric carboxymaltose for heart failure with iron deficiency

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 20, Iss. 1, 2018-01 ,pp. : 134-135

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety and efficacy of intravenous iron polymaltose, iron sucrose and ferric carboxymaltose in pregnancy: A systematic review

AUSTRALIAN AND NEW ZEALAND JOURNAL OF OBSTETRICS AND GYNAECOLOGY, Vol. 58, Iss. 1, 2018-02 ,pp. : 22-39

John Wiley & Sons Inc

Access to resources Recommend Favorite

Iron Deficiency Anemia in Postmenopausal Women*

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 24, Iss. 12, 1976-12 ,pp. : 558-559

John Wiley & Sons Inc

Access to resources Recommend Favorite

A successful desensitization protocol for horse‐derived antithymocyte globulin in severe aplastic anemia

PEDIATRIC ALLERGY AND IMMUNOLOGY, Vol. 26, Iss. 2, 2015-03 ,pp. : 168-172

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron‐deficient heart failure patients: an individual patient data meta‐analysis

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 20, Iss. 1, 2018-01 ,pp. : 125-133

John Wiley & Sons Inc

Access to resources Recommend Favorite